Showing results (271-280 of 369) with videos related to

Sort By:
Pageof 37
ESMO Open|June 26, 2020
ESMO Management and treatment adapted recommendations in the COVID-19 era: Lung cancerAntonio Passaro, Alfredo Addeo, Christophe Von Garnier, et al.
American Journal of Clinical Oncology|June 7, 2007
Activity of weekly paclitaxel in advanced hormone-refractory prostate cancerIsabella Chiappino, Paolo Destefanis, Alfredo Addeo, et al.
CA: a Cancer Journal for Clinicians|July 17, 2025
Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease managementMaxime Borgeaud, Timothée Olivier, Jair Bar, et al.
Global Heart|February 26, 2024
Peer Support for Type 2 Diabetes Management in Low- and Middle-Income Countries (LMICs): A Scoping ReviewDiana Sherifali, Lilian Pinto da Silva, Pooja Dewan, et al.
European Urology Oncology|April 6, 2021
Financial Toxicity Among Patients with Prostate, Bladder, and Kidney Cancer: A Systematic Review and Call to ActionSumeet K Bhanvadia, Sarah P Psutka, Madeleine L Burg, et al.
The Lancet Regional Health. Southeast Asia|July 28, 2026
The burden of childhood cancers in the South Asian Association for Regional Cooperation (SAARC) Region: a population-based, cross-sectional GLOBOCAN 2022 analysisTara Pattilachan Menon, Jazlyn Selvasingh, Taral K Jella, et al.
Translational Lung Cancer Research|September 21, 2020
Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumabGiuseppe Luigi Banna, Diego Signorelli, Giulio Metro, et al.
Therapeutic Advances in Medical Oncology|February 17, 2022
Treatment patterns, testing practices, and outcomes in the pre-FLAURA era for patients with EGFR mutation-positive advanced NSCLC: a retrospective chart review (REFLECT)Alfredo Addeo, Maximilian Hochmair, Urska Janzic, et al.
Journal of Clinical Medicine|March 25, 2022
Real-World Journey of Unresectable Stage III NSCLC Patients: Current Dilemmas for Disease Staging and TreatmentAbed Agbarya, Walid Shalata, Alfredo Addeo, et al.
The Oncologist|July 29, 2022
International Survey on Frailty Assessment in Patients with CancerGiuseppe Luigi Banna, Ornella Cantale, Maria Monica Haydock, et al.
Pageof 37